Literature DB >> 9462511

TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point.

N A Lissy1, L F Van Dyk, M Becker-Hapak, A Vocero-Akbani, J H Mendler, S F Dowdy.   

Abstract

Deletion of antigen-activated T cells after an immune response and during peripheral negative selection after strong T cell receptor (TCR) engagement of cycling T cells occurs by an apoptotic process termed TCR antigen-induced cell death (AID). By analyzing the timing of death, cell cycle markers, BrdU-labeled S phase cells, and phase-specific centrifugally elutriated cultures from stimulated Jurkat T cells and peripheral blood lymphocytes, we found that AID occurs from a late G1 check point prior to activation of cyclin E:Cdk2 complexes. T cells stimulated to undergo AID can be rescued by effecting an early G1 block by direct transduction of p16INK4a tumor suppressor protein or by inactivation of the retinoblastoma tumor suppressor protein (pRb) by transduced HPV E7 protein. These results suggest that AID occurs from a late G1 death check point in a pRb-dependent fashion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9462511     DOI: 10.1016/s1074-7613(00)80458-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  20 in total

1.  T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle.

Authors:  M Karas; T Z Zaks; J L Liu; D LeRoith
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

2.  The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.

Authors:  L F van Dyk; J L Hess; J D Katz; M Jacoby; S H Speck; I V Virgin HW
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein.

Authors:  Nikolay P Nikolov; Masaki Shimizu; Sophia Cleland; Daniel Bailey; Joseph Aoki; Ted Strom; Pamela L Schwartzberg; Fabio Candotti; Richard M Siegel
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

4.  Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity.

Authors:  H Nagahara; S A Ezhevsky; A M Vocero-Akbani; P Kaldis; M J Solomon; S F Dowdy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.

Authors:  S A Ezhevsky; A Ho; M Becker-Hapak; P K Davis; S F Dowdy
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

Review 6.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

7.  BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.

Authors:  K Yamamoto; H Ichijo; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

8.  Activation of human intraepithelial lymphocytes reduces CD3 expression.

Authors:  E C Ebert
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

Review 9.  Biological applications of protein transduction technology.

Authors:  Panagiotis S Kabouridis
Journal:  Trends Biotechnol       Date:  2003-11       Impact factor: 19.536

Review 10.  Cell-Cycle Regulators and Cell Death in Immunity.

Authors:  Sophia G Zebell; Xinnian Dong
Journal:  Cell Host Microbe       Date:  2015-10-14       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.